据美国国务院9月4日消息，美国国务院宣布了一项由“总统防治艾滋病紧急救援计划”（PEPFAR）发起的市场塑造计划，旨在将美国吉利德科学公司的突破性艾滋病药物利那卡帕韦推向艾滋病高负担国家市场，重点预防母婴传播。该计划将促进该药物的全球生产和分销。

https://www.state.gov/releases/the-united-states-presidents-emergency-plan-for-aids-relief/2025/09/pepfars-support-of-american-innovation-to-reach-up-to-2-million-people-by-2028-with-breakthrough-hiv-drug-lenacapavir/?utm_source=homepage&utm_medium=newsbar&utm_campaign=pepfar